Infliximab dose escalation in patients with rheumatoid arthritis in the start trial: The effect of infliximab pharmacokinetics and immunogenicity

被引：0
|
作者：
Rahman, M. U. [1 ]
Strusberg, I. [2 ]
Geusens, P. [3 ]
Berman, A. [4 ]
Wagner, C.
Fasanmade, A.
Han, J.
Westhovens, R. [5 ]
机构：
[1] Centocor Res & Dev Inc, Malvern, PA USA
[2] Ctr Reumatol Strusberg, Cordoba, Argentina
[3] Univ Hosp Maastricht, Maastricht, Netherlands
[4] Hosp Angel C Padilla, San Miguel De Tucuman, Argentina
[5] UZ Gasthuisberg, Louvain, Belgium
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2007年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：184 / 185
页数：2
相关论文
共 50 条
  • [1] Infliximab dose escalation in patients with rheumatoid arthritis in the START study: Influence of Infliximab pharmacokinetics and immunogenicity
    Rahman, M. U.
    Strusberg, I.
    Geusens, P.
    Wagner, C.
    Han, J.
    Westhovens, R.
    [J]. ZEITSCHRIFT FUR RHEUMATOLOGIE, 2007, 66 : 86 - 86
  • [2] Infliximab dose escalation in patients with rheumatoid arthritis: Results from the start trial
    Westhovens, R
    Wolfe, F
    Rahman, MU
    Han, J
    Yocum, D
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 423 - 423
  • [3] Infliximab dose escalation in patients with rheumatoid arthritis: Results from the START trial.
    Westhovens, R
    Wolfe, F
    Rahman, MU
    Han, J
    Yocum, D
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S185 - S186
  • [4] Infliximab dose escalation in RA patients: PK & immunogenicity in the start trial
    Westhovens, R.
    Rahman, M. U.
    Strusberg, I.
    Geusens, P.
    Berman, A.
    Wagner, C.
    Fasanmade, A.
    Xu, S.
    Han, J.
    [J]. RHEUMATOLOGY, 2008, 47 : II15 - II15
  • [5] Dose escalation of infliximab in rheumatoid arthritis
    Haraoui, B
    Cameron, L
    Ouellet, M
    White, B
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2005, 124 (04) : A6 - A6
  • [6] Outcomes of infliximab dose escalation in patients with rheumatoid arthritis
    Cohen, Stanley B.
    Kremer, Joel M.
    Dandreo, Kimberly J.
    Reed, George W.
    Magner, Robert
    Shan, Ying
    Kafka, Shelly
    DeHoratius, Raphael J.
    Ellis, Lorie
    Parenti, Dennis
    [J]. CLINICAL RHEUMATOLOGY, 2019, 38 (09) : 2501 - 2508
  • [7] Outcomes of infliximab dose escalation in patients with rheumatoid arthritis
    Stanley B. Cohen
    Joel M. Kremer
    Kimberly J. Dandreo
    George W. Reed
    Robert Magner
    Ying Shan
    Shelly Kafka
    Raphael J. DeHoratius
    Lorie Ellis
    Dennis Parenti
    [J]. Clinical Rheumatology, 2019, 38 : 2501 - 2508
  • [8] CDAI Analysis of Dose Escalation in a Trial of Infliximab for Rheumatoid Arthritis
    Tesser, John
    Black, Shawn
    Lin, Rongshuang
    Langholff, Wayne
    Uy, Jonathan
    Kafka, Shelly
    [J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [9] Double-blinded infliximab dose escalation in patients with rheumatoid arthritis
    Rahman, Mahboob U.
    Strusberg, Ingrid
    Geusens, Piet
    Berman, Alberto
    Yocum, David
    Baker, Daniel
    Wagner, Carrie
    Han, John
    Westhovens, Rene
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (09) : 1233 - 1238
  • [10] Prediction of dose escalation for rheumatoid arthritis patients under infliximab treatment
    Van Looy, Stijn
    Cruyssen, Bert Vander
    Meeus, Jeroen
    Wyns, Bart
    Westhovens, Rene
    Durez, Patrick
    Van den Bosch, Filip
    Vastesaeger, Nathan
    Geldhof, Anja
    Boullart, Luc
    De Keyser, Filip
    [J]. ENGINEERING APPLICATIONS OF ARTIFICIAL INTELLIGENCE, 2006, 19 (07) : 819 - 828
12345